November 29th & 30th, 2022
December 7th & 8th, 2022
Innovative Solution Providers’ workshop:
How do we keep you in the race of Covid-19?
Monday, December 7th, 2020
11.15 am – 12.30 pm CET
Infectious diseases are caused by pathogenic micro-organisms, such as bacteria, viruses, parasites or fungi; diseases can be transmitted, directly or indirectly, from one person to another.
Three infectious diseases have been ranked among the top ten causes of death worldwide in 2016 by the World Health Organization. These are lower respiratory tract infections (3.0 million deaths), diarrheal diseases (1.4 million deaths) and tuberculosis (1.3 million deaths).
Despite significant progress in research and treatments for infectious diseases, the control and eradication of these diseases still face major challenges. We are currently facing a new emerging infectious disease with the global COVID-19 outbreak caused by the SARS-CoV-2 virus, a type of coronavirus part of a group of RNA viruses (that cause diseases in mammals and birds). Both public research and pharmaceutical industry have been mobilized to find ways to speed up the launch of prophylactic or therapeutic solutions. We have to be SMART to win the race against COVID-19. Different options can be considered, such as substantial investments, drug repositioning, massive consolidation of pharmaceutical companies.
Faced with this fast-paced demand from the pharmaceutical industry, the CROs are coming together to respond quickly and ingeniously to this unprecedented health crisis.
Come and listen to Innovative Providers’ solutions. We will unveil our continuum of specialties to unlock the scientific padlocks linked to Covid-19.
The Innovative Solution Providers gathers French based companies, Oncodesign, Cynbiose, ERBC & PharmaLex. They set-up this specialties companies network to provide the biotech and pharma industry with a full-service offering ranging from hit findings, preclinical research to regulatory developments. These partners have seen an opportunity to provide greater added value services to clients worldwide.
Key learning objectives